This Is MS Multiple Sclerosis Knowledge & Support Community

DMDs reduce lesions in late-onset MS, but don't reduce disability progression. Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis Neurology. 2025 Aug 12;105(3):e213744. Background and objectives : The therapeutic strategy in patients with late-onset MS (LOMS) remains p...

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference Neurology. 2023 Mar 21;100(12):e1296-e1308. Background and objectives : The question of the long-term safety of pregnancy is a major concern in patients with multiple sclerosis (MS), but its s...

Will Olive Oil Protect Your Brain ? Both people and mice getting extra-virgin olive oil in their diets had better cognitive function. It could protect your brain as well. Terry Graedon - August 11, 2025 https://www.peoplespharmacy.com/articles/will-olive-oil-protect-your-brain Scientists have found...

New Concerns About Gabapentin and Pregabalin (Lyrica) for Nerve Pain Concerns about gabapentin and pregabalin prescriptions now include heart failure as well as dementia. What's going on? Joe Graedon - August 07, 2025 https://www.peoplespharmacy.com/articles/new-concerns-about-gabapentin-and-pregab...

Could A PERSONALIZED Exercise Program Save Your Brain? Randomized controlled trials answer the question: Could exercise save your brain? with yes. Following a DASH diet as well may help even more. Joe Graedon - July 31, 2025 https://www.peoplespharmacy.com/articles/could-exercise-save-your-brain Th...

Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease July 31, 2025 07:30 ET https://www.globenewswire.com/news-release/2025/07/31/3124886/29248/en/Anavex-Life-Sci...

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study Ann Neurol. 2025 Aug;98(2):294-307. Objective : To compare clinical and radiological outcomes among relapsing multiple sclerosis patie...

This trial was terminated early due to excessive inflammatory disease activity in the discontinuation treatment arm. Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial JAMA Neurol. 2025 Feb 1;82(2):123-131. Importa...

Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis Lancet Neurol. 2025 May;24(5):413-428. Background : There remains a substantial unmet need for effective and safe treatments for neuropathic pain. The Neuropathic Pain Special Interest Group...

DIM wrote: ↑Mon Jun 30, 2025 1:55 am MAy I ask you where from did you order the 4-AP-3-MeOH?

Have you checked with compounding pharmacies?

The New York Times reports that Robert F. Kennedy Jr.’s “Make America Health Again” report cited fake studies.

Amazing. This is Helius Medical's 5th reverse stock split. The reverse split history is now 1:4, 1:35, 1:50, 1:15 and 1:50. Helius Medical Technologies Announces Reverse Stock Split June 27, 2025 08:30 ET https://www.globenewswire.com/news-release/2025/06/27/3106547/0/en/Helius-Medical-Technologies-...

Anticholinergic drugs increase the risk of brain atrophy. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults JAMA Neurol. 2016 Jun 1;73(6):721-32. Importance : The use of anticholinergic (AC) medication is linked t...

Unexpected GLP-1 Side Effects with Ozempic, Wegovy and MANY Other Drugs It can take the FDA decades to discover bad drug reactions. Are there unexpected GLP-1 side effects with Ozempic and Wegovy that affect eyes? Joe Graedon - June 12, 2025 https://www.peoplespharmacy.com/articles/beware-unexpect ...

Here's Nervgen's presentation reporting the chronic treatment arm results.

https://nervgen.com/wp-content/uploads/ ... -final.pdf